Pharma Deals Review, Vol 2010, No 6 (2010)

Font Size:  Small  Medium  Large

Forest Licenses Novel Diabetes Compounds from TransTech Pharma

Debbie Tranter

Abstract


Forest Laboratories is paying up to USD 1.105 B to in-licence novel liver-selective Glucokinase Activators discovered by TransTech Pharma and currently in preclinical and Phase I stages.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.